1.Study of sequencing of VP4, VP7, NSP1, NSP4 genes of human rotavirus strain G4P6 (2001019203)
Huong Thu Ngo ; Hien Dang Nguyen
Journal of Preventive Medicine 2007;17(5):10-14
Background: Rotavirus is the main cause of acute viral gastroenteritis in children under 5 years old. In Viet Nam, about 50-70% hospitalized children with acute diarrhea caused by rotavirus. This indicated the importance of vaccination against diarrhea in Vietnam and researching on creating safe diarrhea vaccine for infants was a imperative. To achieve a good result of the research, it\u2019s necessary to understand the genetic characteristics of rotavirus.Objectives: To determine sequencing of VP4, VP7, NSP1, NSP4 genes of human rotavirus strain G4P6. Subjects and method: The research was performed on rotavirus samples (203pp16TK; 203pp27TK; 203pp30vero; 203pp37vero; 203pp38vero lot11; 203pp38TK lot12) by using ARN separation and RT-PCR methods. Results and Conclusion: We presented the results of sequencing of VP4, VP7, NSP1, NSP4 genes in some passages of human rotavirus strain G4P6 including their deduced amino acid sequence. The nucleotide mutants of VP7, NSP4 genes of passages are 2, 1 respectively. All the mutants result in amino acid changes. There was no mutation on VP4, NSP1 genes. The result confirmed that all passages of human rotavirus strain G4P6 had no contamination. They had similar degree respectively 89-93%, 85-97%, 81-93%, 92-95% with strains in the world.
Rotavirus/ pathogenicity
2.Efficacy of Novalac AD in the treatment of infantile rotavirus enteritis.
Chinese Journal of Experimental and Clinical Virology 2010;24(2):145-146
OBJECTIVETo observe clinical efficacy of Novalac AD in infantile rotavirus enteritis.
METHODS20 infants with rotavirus enteritis but without dehydration and/or acidosis were selected to be fed by Novalac AD for one week.
RESULTSEffective rate was 100%. All 20 subjects stool turned normal and systemic symptoms disappeared after treatment, with 17 within 48 h (85%,17/20) and 3 within 72 h (15%, 3/20).
CONCLUSIONNovalac AD has a significant effect on infantile rotavirus enteritis.
Antiviral Agents ; therapeutic use ; Enteritis ; drug therapy ; virology ; Humans ; Infant ; Infant, Newborn ; Rotavirus ; drug effects ; pathogenicity ; Rotavirus Infections ; drug therapy ; virology